Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$ALPMY

ASTELLAS PHARMA UNSP/ADR

OTC Link

$15.05
+0.00%+$0.000
RVOL peak today
Normal
Halted today
None today
Float
Unknown
Next earnings
Unscheduled
$15.05+0.00%+$0.0000Prev $15.05LIVE Full chart Live alerts
No recent price bars, the chart lights up when ALPMY starts printing.

Why is ALPMY up today? It is at $15.05 (+0.00%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALPMY spikes, and full due diligence on ALPMY — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $ALPMY alerts the moment volume spikes

Our scanner flagged $ALPMY 2 times in the last 30 days. Create a free account to track $ALPMY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$15.05
Change today
+0.00%
Previous close
$15.05
Valuation & dividend
Dividend yield
10.77% ($1.62)
Ownership & volume
Short interest
71K
▲ +69% vs prior · as of 2026-07-31
Days to cover
1.0d
Classification
Exchange
OTC Link
Relative volumevs this time of day
5m
0.1x
15m
0.2x
1h
0.3x
1D
--

Get free ALPMY + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $ALPMY moving today?

Here is the latest on ALPMY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALPMY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Why is $ALPMY moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileShortableEasy to borrowNo SSRBorrow via Alpaca · SSR from Reg SHO 201

$ALPMY Sentiment

Bullish
Bearish78Bullish
📰 News: 7 bull · 0 bearToday: +0.0%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$ALPMY Activity

News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.

Alert· 3d ago +2.2% vs EMA
ALPMY 200EMA (5m) Trending · 56 bars · L3 · +2.24% above EMA · slope +0.38%
at $15.08
Alert· 3d ago +0.9% vs EMA
ALPMY 50EMA (5m) Trending · 57 bars · L3 · +0.93% above EMA · slope +0.57%
at $15.08
Alert· 3d ago +1.7% vs EMA
ALPMY 200EMA (1m) Trending · 105 bars · L4 · +1.74% above EMA · slope +0.31%
at $15.08
Alert· 4d ago 3.7× RVOL
ALPMY hit 3.718x RVOL at 10:26 AM ET
at $14.99
Alert· 25d ago +2.0% vs EMA
ALPMY 200EMA (5m) Trending · 52 bars · L3 · +1.97% above EMA · slope +0.52%
at $13.95
Alert· 25d ago +0.1% vs EMA
ALPMY 50EMA (5m) Trending · 52 bars · L3 · +0.06% above EMA · slope +0.52%
at $13.95
Alert· 25d ago +1.3% vs EMA
ALPMY 200EMA (1m) Trending · 81 bars · L3 · +1.27% above EMA · slope +0.38%
at $13.95
Alert· 25d ago 10.5× RVOL
ALPMY hit 10.499x RVOL at 11:30 AM ET
at $13.93
Alert· 34d ago +0.3% vs EMA
ALPMY 200EMA (5m) Trending · 52 bars · L3 · +0.33% above EMA · slope +0.08%
at $13.28
Alert· 34d ago +0.2% vs EMA
ALPMY 50EMA (1m) Trending · 63 bars · L3 · +0.18% above EMA · slope +0.08%
at $13.30
Alert· 34d ago 13.3× RVOL
ALPMY hit 13.301x RVOL at 2:12 PM ET
at $13.30
News· GlobeNewswire Inc.· 74d ago Bullish
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
News· GlobeNewswire Inc.· 90d ago Bullish
Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035
News· GlobeNewswire Inc.· 124d ago Bullish
Oncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights
News· GlobeNewswire Inc.· 125d ago Bullish
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
News· GlobeNewswire Inc.· 132d ago Bullish
$5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036
News· The Motley Fool· 133d ago Neutral
Vir Biotechnology (VIR) CEO Sells 73,000 Shares for $664,000
News· GlobeNewswire Inc.· 213d ago Bullish
4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer
News· GlobeNewswire Inc.· 265d ago Bullish
Geographic Atrophy Market to Surge Significantly During the Forecast Period (2025–2034) Due to Rising Adoption of Complement Inhibitor Therapies | DelveInsight

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

ALPMY stock FAQ

Why is $ALPMY moving today?

Here is the latest on ALPMY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ALPMY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the ALPMY stock price today?

ALPMY last traded at $15.05, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

Does ALPMY pay a dividend?

Yes. ALPMY currently has a dividend yield of about 10.77% ($1.62 per share per year). Dividend figures can change; this is not investment advice.

Where can I see live ALPMY alerts?

The ALPMY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALPMY 2 times in the last 30 days.

What exchange is ALPMY on?

ALPMY (ASTELLAS PHARMA UNSP/ADR) trades on OTC Link.

Is ALPMY good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALPMY for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.